Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of meldonium in chronic ischemic heart failure
CTR20140220Phase 3Suspended
- Sponsor
- Grindeks
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of meldonium in ischaemic cardiomyopathy (ICM), sponsored by Grindeks. Started Apr 2014; status: suspended.
02
Drugs
meldonium
03
Conditions
ischaemic cardiomyopathy (ICM)
Beyond the preview
Go deeper on CTR20140220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140220.